This presentation will focus on clinical guidance/recommendations on PFAS blood or urine testing, recommended guidance on how clinicians can advise patients on PFAS testing and health outcomes that may be associated with PFAS, as well as what to advise patients regarding standard medical or preventive care and exposure reduction.
Alex Kemper, MD | The Ohio State University
Dr. Kemper is the Division Chief of Primary Care Pediatrics at Nationwide Children’s Hospital and Professor of Pediatrics at The Ohio State University College of Medicine. The focus of his research is the evaluation of preventive services delivered in the primary care setting. He currently serves as the Chair of the Evidence Review Workgroup for the U.S. Secretary of Health and Human Services Advisory Committee on Heritable Disorders in Newborns and Children and is the Deputy Editor of PEDIATRICS. He is a former member of the US Preventive Services Task Force and has served on the National Academies of Science, Engineering, and Medicine planning committee on special nutritional requirements for disease states. He was a co-author for the recent National Academies of Sciences, Engineering and Medicine (NASEM) report, Guidance on PFAS Exposure, Testing, and Clinical Follow-up (2022)
Each participant will earn one CE for attending each session. There is no cost for participating in any of the sessions.
Villanova University M. Louise Fitzpatrick College of Nursing is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.